Description
Human Placenta Tissue LiquidProduct Specifications
| Parameter | Details |
|---|---|
| Product Name | Human Placenta Tissue Liquid (Geshun) |
| Brand / Chinese Name | Geshun (??) |
| Formulation | Injectable solution |
| Strength / Volume | 2?mL per vial |
| Pack Size | 10 vials per box |
| Dosage Form | Injection (intramuscular) |
| Approval Number | NMPA China: S43020001 |
| Product Code | 86904995000468 |
| Manufacturer | Hunan Yige Pharmaceutical Co., Ltd. |
| Barcode | 6922274450166 |
| Composition | Acid-hydrolyzed human placental tissue + sodium chloride bpglobalusa.com+1pmc.ncbi.nlm.nih.gov+1 |
| Storage | Refrigerate at 2–8?°C, protect from light |
| Intended Use | Laboratory research use only |
Human Placenta Tissue Liquid Mechanism of Action
Acid-hydrolyzed human placenta extract is rich in growth factors, peptides, and cytokines with anti-inflammatory, antioxidant, and tissue repair properties. These bioactive components support cellular regeneration and modulate local immune responses in chronic inflammation models .
Research Applications & Usage
Indications in research:
Chronic gynecologic/dermatologic inflammation
Scarring and adhesion inhibition post-surgery
Respiratory mucosal repair (e.g., chronic tracheitis)
Typical dosing:
Intramuscular injection of 1–2?mL once daily or every other day
A standard course: ~30 injections with 1-week intermission between cycles
Safety Profile & Handling
Adverse Events & Precautions:
Common side effects: rarely reported none in large studies
Contraindications: not specified—refer to institutional guidelines
Always inspect vials for particulates before use
Handling & Storage:
Store at 2–8?°C, shielded from light
Wear standard lab PPE (gloves, mask, coat)
Dispose as per biohazard waste protocols
?? Research Use Disclaimer
This product is exclusively intended for laboratory research use. It is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may present safety hazards and violate regulations.


Reviews
There are no reviews yet.